Propanc Biopharma, Inc. (PPCB): Free Cash Flow
-$5.69M
Year ended 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | -$5.69M | n/a | 2026-09-25, From 2025-07-01 |
| No annual figure between 2019-06-30 and 2026-06-30. | |||
| 2019-06-30 | -$2.06M | n/a | 2020-10-01, From 2018-07-01 |
| No annual figure between 2014-06-30 and 2019-06-30. | |||
| 2014-06-30 | $226.4K | n/a | 2015-09-30, From 2013-07-01 |
| No annual figure between 2011-06-30 and 2014-06-30. | |||
| 2011-06-30 | -$1.40M | n/a | 2012-10-15, From 2010-07-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Propanc Biopharma, Inc. (PPCB) | 2026-06-30 | -$5.69M | n/a |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | -$6.38M | n/m |
| Imunon, Inc. (IMNN) | 2025-12-31 | -$14.18M | n/m |
| CalciMedica, Inc. (CALC) | 2025-12-31 | -$21.21M | n/m |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | -$3.96M | n/m |
| Chemomab Therapeutics Ltd. (CMMB) | 2025-12-31 | -$11.13M | n/m |
| Exicure, Inc. (XCUR) | 2025-12-31 | -$8.56M | n/m |
| NewcelX Ltd. (NCEL) | 2025-12-31 | -$2.77M | n/m |
| MetaVia Inc. (MTVA) | 2025-12-31 | -$15.70M | n/m |
Compare PPCB, ELAB, IMNN, CALC side by side · Screen every company in Pharmaceutical Preparations ↗